Article
Monoclonal Antibody Therapies in Chronic Inflammatory Diseases: Periodontal Outcomes, Oral Safety and Clinical Implications—A Scoping Review
2026-08-05
Abstract excerpt
Monoclonal antibody-based therapies are widely used in chronic immune-mediated diseases, yet periodontal effects, dentoalveolar safety signals and exposure characteristics remain incompletely characterized. This scoping review mapped periodontal outcomes, safety signals, administration, exposure and pharmaceutical-context reporting in adults. PubMed, Scopus and Web of Science were searched in July 2026 without pub...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4f220992-f2f6-514c-a509-30c22b7db252
- DOI
- 10.20944/preprints202608.0250.v1
